# FDA Inspection 1244249 - Shandong Keyuan Pharmaceutical Co., Ltd. - June 14, 2024

Source: https://www.keypedia.com/records/fda_inspections/shandong-keyuan-pharmaceutical-co-ltd/5f3452f6-d7ba-4d4f-80b0-8223d7584aee
Source feed: FDA_Inspections

> FDA Inspection 1244249 for Shandong Keyuan Pharmaceutical Co., Ltd. on June 14, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1244249
- Company Name: Shandong Keyuan Pharmaceutical Co., Ltd.
- Inspection Date: 2024-06-14
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1064715 - 2018-08-02](https://www.keypedia.com/records/fda_inspections/shandong-keyuan-pharmaceutical-co-ltd/165ba864-3231-419e-94b0-f03f7b3a3d50)
- [FDA Inspection 927100 - 2015-04-10](https://www.keypedia.com/records/fda_inspections/shandong-keyuan-pharmaceutical-co-ltd/aaf4e02c-e992-459b-8c01-d0358a14b273)

Company: https://www.keypedia.com/companies/shandong-keyuan-pharmaceutical-co-ltd/971cc218-ba72-4cf7-a172-a4cb1627cb39

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c